0

Purchase Short-Term Access

Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
Gurinder Luthra, MD; P. Jay Pasricha, MD


Annals of Internal Medicine 2002;136:92. doi:10.7326/ACPJC-2002-136-3-092

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)